Predicting the individualized risk of nonadherence to zoledronic acid among osteoporosis patients receiving the first infusion of zoledronic acid: development and validation of new predictive nomograms

INTRODUCTION: Achieving optimal adherence to zoledronic acid (ZOL) among osteoporosis (OP) patients is a challenging task. Here, we aimed to develop and validate a precise and efficient prediction tool for ZOL nonadherence risk in OP patients. METHODS: We prospectively collected and analyzed survey...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chong, Lu, Ke, Shi, Qin, Gong, Ya-qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340933/
https://www.ncbi.nlm.nih.gov/pubmed/35924011
http://dx.doi.org/10.1177/20406223221114214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340933/
https://www.ncbi.nlm.nih.gov/pubmed/35924011
http://dx.doi.org/10.1177/20406223221114214

Ejemplares similares